USBasic Materials

BioNexus Gene Lab Corp Common stock (BGLC)

US · Basic Materials · Specialty Chemicals

$1.54+7.69%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$22,842
Revenue YoY
-98.9%
Net profit
$-543,575
Profit YoY
+12.8%
EPS
$-0.22
Net margin
-2,379.7%

Key statistics

Market cap
$3.5M
Forward P/E
0.0
P/B
0.39
Book value
$3.35
EPS (TTM)
$-1.49
52-week high
$6.10
52-week low
$1.07
50-day MA
$1.98
200-day MA
$2.97
Beta
2.19

Shareholding

Insiders
35.59%
Institutions
0.01%

Largest institutional holders

FundStake
UBS Group AG0.01%
Wells Fargo & Co0.00%
DRW Securities, LLC0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for BioNexus Gene Lab Corp Common stock — free to start.

Google PlayApp Store

Other Basic Materials companies

Data updated 2026-08-05.